Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Determinants of HIV-1 Late Presentation in Patients Followed in Europe.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Farmacogenética y Farmacogenómica.Microbioma intestinal
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
A summary of the sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment.
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.
Impact of pre-existing drug resistance on risk of virological failure in South Africa.
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.